Cimbi-36

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2015
01220122015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
INTRODUCTION [(11)C]Cimbi-36 is a recently developed serotonin 2A (5-HT2A) receptor agonist positron emission tomography (PET… (More)
  • table 1
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2016
2016
  • Federal register
  • 2016
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration places three synthetic… (More)
Is this relevant?
2016
2016
Positron emission tomography (PET) investigations of the 5-HT2A receptor (5-HT2AR) system can be used as a research tool in… (More)
Is this relevant?
2016
2016
INTRODUCTION The serotonin 2A receptor (5-HT2AR) is the most abundant excitatory 5-HT receptor in the human brain and implicated… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2015
2015
Individual differences in coping style emerge as a function of underlying variability in the activation of a mesocorticolimbic… (More)
  • figure 1
  • table I
  • figure 2
  • table II
Is this relevant?
2015
2015
  • Federal register
  • 2015
The Administrator of the Drug Enforcement Administration is issuing this final order extending the temporary schedule I status… (More)
Is this relevant?
2013
2013
  • Federal register
  • 2013
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three… (More)
Is this relevant?
2012
2012
[11C]Cimbi-36 was recently developed as an agonist radioligand for brain imaging of serotonin 2A receptors (5-HT2A) with positron… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?